Literature DB >> 15849530

Predictors of chronic pelvic pain in an urban population of women with symptoms and signs of pelvic inflammatory disease.

Catherine L Haggerty1, Jeffrey F Peipert, Sherry Weitzen, Susan L Hendrix, Robert L Holley, Deborah B Nelson, Hugh Randall, David E Soper, Harold C Wiesenfeld, Roberta B Ness.   

Abstract

OBJECTIVE: The objective of this study was to assess the risk profile for chronic pelvic pain (CPP) after pelvic inflammatory disease (PID). STUDY: Multivariate logistic regression was used to assess risk factors for CPP in a longitudinal study of 780 predominately black, urban women with clinically suspected PID: complaints of acute pain (<30 days); a clinical finding of pelvic tenderness; and leukorrhea, mucopurulent cervicitis, or untreated gonococcal or chlamydial cervicitis. CPP was defined as pain reported at >or=2 consecutive interviews conducted every 3 to 4 months for 2 to 5 years.
RESULTS: Nonblack race (odds ratio [OR], 2.17; 95% confidence interval [CI], 1.31-3.58), being married (OR, 2.06; 95% CI, 1.02-4.18), a low SF-36 mental health composite score (OR, 2.71; 95% CI, 1.69-4.34), >or=2 prior PID episodes (OR, 2.84; 95% CI, 1.07-7.54), and smoking (OR, 1.65; 95% CI, 1.01-2.71) independently predicted CPP. Histologic endometritis or evidence of endometrial Neisseria gonorrhoeae or Chlamydia trachomatis infection was negatively associated with CPP (OR, 0.69; 95% CI, 0.44-1.10).
CONCLUSIONS: A range of demographic, clinical, historical, and behavioral factors predict CPP after PID.

Entities:  

Mesh:

Year:  2005        PMID: 15849530     DOI: 10.1097/01.olq.0000162361.69041.a5

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  10 in total

Review 1.  Status of adolescent pelvic inflammatory disease management in the United States.

Authors:  Maria Trent
Journal:  Curr Opin Obstet Gynecol       Date:  2013-10       Impact factor: 1.927

2.  Microbial correlates of delayed care for pelvic inflammatory disease.

Authors:  Brandie D Taylor; Roberta B Ness; Toni Darville; Catherine L Haggerty
Journal:  Sex Transm Dis       Date:  2011-05       Impact factor: 2.830

3.  Etiology and Diagnosis of Pelvic Inflammatory Disease: Looking Beyond Gonorrhea and Chlamydia.

Authors:  Caroline M Mitchell; Gloria E Anyalechi; Craig R Cohen; Catherine L Haggerty; Lisa E Manhart; Sharon L Hillier
Journal:  J Infect Dis       Date:  2021-08-16       Impact factor: 7.759

4.  Fuke Qianjin Combined with Antibiotic Therapy for Pelvic Inflammatory Disease: A Systematic Review and Meta-Analysis.

Authors:  Yu Chen; Shaobin Wei; Li Huang; Mei Luo; Yang Wu; Caimmiao Yin
Journal:  Evid Based Complement Alternat Med       Date:  2020-07-21       Impact factor: 2.629

5.  Clinical presentation of Mycoplasma genitalium Infection versus Neisseria gonorrhoeae infection among women with pelvic inflammatory disease.

Authors:  Vanessa L Short; Patricia A Totten; Roberta B Ness; Sabina G Astete; Sheryl F Kelsey; Catherine L Haggerty
Journal:  Clin Infect Dis       Date:  2009-01-01       Impact factor: 9.079

Review 6.  Pelvic inflammatory disease: current concepts in pathogenesis, diagnosis and treatment.

Authors:  Caroline Mitchell; Malavika Prabhu
Journal:  Infect Dis Clin North Am       Date:  2013-10-31       Impact factor: 5.982

7.  Development and Feasibility of a Group-Based Therapeutic Yoga Program for Women with Chronic Pelvic Pain.

Authors:  Alison J Huang; Tami S Rowen; Priscilla Abercrombie; Leslee L Subak; Michael Schembri; Traci Plaut; Maria T Chao
Journal:  Pain Med       Date:  2017-10-01       Impact factor: 3.750

8.  Management of Chlamydia trachomatis genital tract infection: screening and treatment challenges.

Authors:  Brandie D Taylor; Catherine L Haggerty
Journal:  Infect Drug Resist       Date:  2011-01-20       Impact factor: 4.003

Review 9.  Pathogenesis of Neisseria gonorrhoeae and the Host Defense in Ascending Infections of Human Fallopian Tube.

Authors:  Jonathan D Lenz; Joseph P Dillard
Journal:  Front Immunol       Date:  2018-11-21       Impact factor: 7.561

Review 10.  Can Botulinum Toxin A Play A Role In Treatment Of Chronic Pelvic Pain Syndrome In Female Patients?-Clinical and Animal Evidence.

Authors:  Chin-Li Chen; En Meng
Journal:  Toxins (Basel)       Date:  2020-02-10       Impact factor: 4.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.